Phase I trial of capecitabine with cemiplimab in patients with hormone receptor–positive metastatic breast cancer.

Authors: Aixa Elena Soyano Muller, Aryanna Jordan, Jennifer A. Childress, Biwei Cao, Qianxing Mo, Saeed Bajestani, Jerry Owens, Dawn Goodridge, Avan J. Armaghani, Ricardo L. Costa, Hyo S. Han, Hatem Hussein Soliman, Loretta S. Loftus, Brian J. Czerniecki, Hung T. Khong

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e13082

Source: Full article

---

Abstract

e13082